[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"ProVerum Medical\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":24,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100645393","provide-studies-post-exit-analysis-100645393",false,"NCT07680543","ProVIDE Studies Post Exit Analysis","Inclusion Criteria:\n\n* 1\\. US based subjects previously enrolled in the ProVIDE Study or the ProVIDE II Bridging Study who had a ProVee device removed.\n* 2\\. Subjects who withdrew consent or were withdrawn by site Study PI.\n* 3\\. Subjects consented to make data available.\n\nExclusion Criteria:\n\n* 1\\. Incomplete records available.\n* 2\\. Subjects who exited the studies due to restarting BPH medication while they were enrolled.\n* 3\\. Subjects who did not receive a ProVee in the ProVIDE Study or the ProVIDE II Bridging Study.\n* 4\\. Subjects who exited the studies due to prostate cancer.","MALE","45 Years",{"count":18,"type":19},25,"ESTIMATED","OBSERVATIONAL","A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.",[23],"BPH With Symptomatic Lower Urinary Tract Symptoms",[25],"BPH \u002F LUTS","NOT_YET_RECRUITING","2026-06-25",{"date":29,"type":30},"2026-07-02","ACTUAL",{"date":32,"type":19},"2026-07-14",{"date":34,"type":19},"2029-07-31",{"name":36,"class":37},"ProVerum Medical","INDUSTRY",""]